Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
29.7M
-
Shares change
-
-270K
-
Total reported value, excl. options
-
$369M
-
Value change
-
-$4.19M
-
Put/Call ratio
-
1.05
-
Number of buys
-
43
-
Number of sells
-
-39
-
Price
-
$12.43
Significant Holders of MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) as of Q2 2022
108 filings reported holding MYOV - MYOVANT SCIENCES LTD - COMMON STOCK-FO as of Q2 2022.
MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.7M shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (6.42M shares), Bellevue Group AG (5.92M shares), JANUS HENDERSON GROUP PLC (5.45M shares), STATE STREET CORP (2.23M shares), BlackRock Inc. (1.1M shares), CITADEL ADVISORS LLC (969K shares), VANGUARD GROUP INC (859K shares), MARSHALL WACE, LLP (633K shares), GEODE CAPITAL MANAGEMENT, LLC (419K shares), and GOLDMAN SACHS GROUP INC (418K shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.